Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

Johnson & Johnson to Participate in the Leerink Global Biopharma Conference




Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).


This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Contacts

Media contact:

media-relations@its.jnj.com

Investor contact:
investor-relations@its.jnj.com